The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $172,599.60 firm-fixed-price purchase order to Infinity Biologix LLC, doing business as Sampled Division, for whole genome sequencing services. This contract does not have a socioeconomic set-aside. Infinity Biologix is a leading provider of genomic analysis, sequencing, and biorepository services that has supported various federal agencies, including the Department of Veterans Affairs, Department of Agriculture, and Centers for Disease Control and Prevention. Through this award, Infinity Biologix will provide NIAID, a civilian agency within the National Institutes of Health, with whole genome sequencing services. The contract runs through December 31, 2024. Infinity Biologix holds several other major federal indefinite delivery contracts for genomic analysis and next-generation sequencing services.
Generated 10/1/24, 10:50 AM